Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aram Nazareth Demirjian, M.D.


This page shows the publications co-authored by Aram Demirjian and Mark Callery.
Connection Strength

  1. Demirjian AN, Vollmer CM, McDermott DF, Mullen JT, Atkins MB, Callery MP. Refining indications for contemporary surgical treatment of renal cell carcinoma metastatic to the pancreas. HPB (Oxford). 2009 Mar; 11(2):150-3.
    View in: PubMed
    Score: 0.443
  2. Demirjian AN, Callery MP. Environment, genetics, and fish? Answers to the cancer riddle. Gastroenterology. 2006 Mar; 130(3):1000-1.
    View in: PubMed
    Score: 0.360
  3. Demirjian AN, Kent TS, Callery MP, Vollmer CM. The inconsistent nature of symptomatic pancreatico-jejunostomy anastomotic strictures. HPB (Oxford). 2010 Sep; 12(7):482-7.
    View in: PubMed
    Score: 0.123
  4. Bai J, Demirjian A, Sui J, Marasco W, Callery MP. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. Biochem Biophys Res Commun. 2006 Oct 06; 348(4):1245-53.
    View in: PubMed
    Score: 0.093
  5. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Cancer Res. 2005 Mar 15; 65(6):2344-52.
    View in: PubMed
    Score: 0.084
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.